CLN6（ceroid-lipofuscinosis, neuronal 6, late infantile, variant） is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.蛋白别名为：CLN6; Ceroid-lipofuscinosis neuronal protein 6; Protein CLN6;基因ID为：54982；蛋白质ID:Q9NWW5
应用类型
WB，IHC-p，ELISA补充：最优的抗体稀释比例需要基于客户实验进行优化.建议的起始稀释比例如下: WB: 1:500-1:2000, IHC-p: 1:100-1:300, ELISA: 1:40000. Not yet tested in other applications.
免疫原
合成多肽：the C-terminal region of human CLN6. at AA rangle: 190-270
